🇺🇸 FDA
Patent

US 8436014

Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8436014 (Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide) held by Vertex Pharmaceuticals Incorporated expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/16